Zhuhai Sailong Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This ESG score covers seventeen United Nations Sustainable Development Goals including: 'Clean Water & Sanitation', 'Reduced Inequalities' and 'Life below Water'. This webpage contains a free Environmental, Social and Governance assessment for Zhuhai Sailong Pharmaceutical Co Ltd. Check the bottom of the page for potential risks for Zhuhai Sailong Pharmaceutical Co Ltd based on industry, geography and size.
Zhuhai Sailong Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Zhuhai Sailong Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Zhuhai Sailong Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Zhuhai Sailong Pharmaceutical Co Ltd report the average age of the workforce?
Does Zhuhai Sailong Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Zhuhai Sailong Pharmaceutical Co Ltd offer flexible work?
Does Zhuhai Sailong Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Zhuhai Sailong Pharmaceutical Co Ltd conduct supply chain audits?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Zhuhai Sailong Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose water use targets?
Does Zhuhai Sailong Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Zhuhai Sailong Pharmaceutical Co Ltd have a product recall in the last two years?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Zhuhai Sailong Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Zhuhai Sailong Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose parental leave metrics?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Zhuhai Sailong Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Zhuhai Sailong Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Zhuhai Sailong Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose its waste policy?
Does Zhuhai Sailong Pharmaceutical Co Ltd report according to TCFD requirements?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose energy use targets?
Does Zhuhai Sailong Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Zhuhai Sailong Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Zhuhai Sailong Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding medicine, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.